603367.SS · 辰欣药业
China A-shares · RS rating 49 · As of 2026-10-14
| Price | 13.96 CNY |
|---|---|
| 1-day change | -1.0% |
| RS rating (overall / 1M / 3M / 12M) | 49 / 60 / 64 / 20 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 27 / 26 / 22 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -0.9% |
| Distance from 52-week high | +42.3% |
| Market cap (USD) | $977.7M |